Elvin D. de Araujo

1.2k total citations
37 papers, 495 citations indexed

About

Elvin D. de Araujo is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Elvin D. de Araujo has authored 37 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Oncology and 6 papers in Immunology. Recurrent topics in Elvin D. de Araujo's work include Histone Deacetylase Inhibitors Research (12 papers), Protein Degradation and Inhibitors (11 papers) and Cytokine Signaling Pathways and Interactions (11 papers). Elvin D. de Araujo is often cited by papers focused on Histone Deacetylase Inhibitors Research (12 papers), Protein Degradation and Inhibitors (11 papers) and Cytokine Signaling Pathways and Interactions (11 papers). Elvin D. de Araujo collaborates with scholars based in Canada, United States and Austria. Elvin D. de Araujo's co-authors include Patrick T. Gunning, Richard Moriggl, Anna Orlova, György M. Keserű, Dávid Bajusz, Voula Kanelis, Heidi A. Neubauer, Yasir S. Raouf, Marco Herling and Christina Wagner and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Elvin D. de Araujo

34 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elvin D. de Araujo Canada 13 305 226 68 60 54 37 495
Fiona H. Tan Australia 11 302 1.0× 150 0.7× 57 0.8× 41 0.7× 67 1.2× 20 591
Ann Palladino United States 4 352 1.2× 109 0.5× 44 0.6× 39 0.7× 32 0.6× 5 524
Lata Chauhan United States 8 313 1.0× 159 0.7× 39 0.6× 22 0.4× 50 0.9× 15 489
Silvia Escudero United States 7 379 1.2× 201 0.9× 30 0.4× 29 0.5× 32 0.6× 8 489
Ayşe Latif United Kingdom 14 227 0.7× 153 0.7× 40 0.6× 27 0.5× 49 0.9× 26 645
Indranil Basu United States 9 344 1.1× 158 0.7× 70 1.0× 28 0.5× 21 0.4× 17 543
Ziqian Wang China 15 431 1.4× 86 0.4× 79 1.2× 19 0.3× 54 1.0× 45 618
Yvonne Li Canada 9 381 1.2× 161 0.7× 48 0.7× 43 0.7× 24 0.4× 15 525
Alexander Bolaender United States 12 334 1.1× 161 0.7× 69 1.0× 24 0.4× 17 0.3× 14 547
Sachiko Tai Japan 8 182 0.6× 114 0.5× 88 1.3× 35 0.6× 50 0.9× 12 381

Countries citing papers authored by Elvin D. de Araujo

Since Specialization
Citations

This map shows the geographic impact of Elvin D. de Araujo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elvin D. de Araujo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elvin D. de Araujo more than expected).

Fields of papers citing papers by Elvin D. de Araujo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elvin D. de Araujo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elvin D. de Araujo. The network helps show where Elvin D. de Araujo may publish in the future.

Co-authorship network of co-authors of Elvin D. de Araujo

This figure shows the co-authorship network connecting the top 25 collaborators of Elvin D. de Araujo. A scholar is included among the top collaborators of Elvin D. de Araujo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elvin D. de Araujo. Elvin D. de Araujo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gracia-Hernandez, Maria, Abootaleb Sedighi, Mulu Geletu, et al.. (2025). Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications. Journal of Medicinal Chemistry. 68(17). 18216–18229.
2.
Sedighi, Abootaleb, et al.. (2025). Monoselective Histone Deacetylase 6 PROTAC Degrader Shows In Vivo Tractability. Journal of Medicinal Chemistry. 68(6). 6165–6177. 5 indexed citations
3.
Lorenzo, V. di, László Petri, Elvin D. de Araujo, et al.. (2025). Allosteric Covalent Inhibitors of the STAT3 Transcription Factor from Virtual Screening. ACS Medicinal Chemistry Letters. 16(6). 991–997. 1 indexed citations
4.
Araujo, Elvin D. de, et al.. (2024). The structural influence of the oncogenic driver mutation N642H in the STAT5B SH2 domain. Protein Science. 34(1). e70022–e70022.
5.
Bajusz, Dávid, et al.. (2023). SH2db, an information system for the SH2 domain. Nucleic Acids Research. 51(W1). W542–W552. 5 indexed citations
6.
Raouf, Yasir S., et al.. (2023). Discovery of YSR734: A Covalent HDAC Inhibitor with Cellular Activity in Acute Myeloid Leukemia and Duchenne Muscular Dystrophy. Journal of Medicinal Chemistry. 66(24). 16658–16679. 9 indexed citations
7.
Araujo, Elvin D. de, et al.. (2023). Medicinal chemistry advances in targeting class I histone deacetylases. SHILAP Revista de lepidopterología. 4(4). 757–779. 10 indexed citations
8.
Araujo, Elvin D. de, et al.. (2021). Optical chemosensors for the detection of proximally phosphorylated peptides and proteins. RSC Chemical Biology. 2(3). 815–829. 10 indexed citations
9.
Hadzijusufovic, Emir, et al.. (2021). Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD+ Acute Myeloid Leukemia. Cancers. 13(24). 6181–6181. 3 indexed citations
10.
Hassan, Muhammad Murtaza, Johan Israelian, Yasir S. Raouf, et al.. (2020). Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting. Journal of Medicinal Chemistry. 63(15). 8634–8648. 33 indexed citations
11.
Araujo, Elvin D. de, et al.. (2020). Sensitive Detection of Broad-Spectrum Bacteria with Small-Molecule Fluorescent Excimer Chemosensors. ACS Sensors. 5(9). 2753–2762. 21 indexed citations
12.
Gawel, Justyna M., Yasir S. Raouf, Johan Israelian, et al.. (2020). PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia. European Journal of Medicinal Chemistry. 201. 112411–112411. 33 indexed citations
13.
Shah, Fenil, Justyna M. Gawel, Yasir S. Raouf, et al.. (2019). Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer. Journal of Medicinal Chemistry. 62(5). 2651–2665. 28 indexed citations
14.
Araujo, Elvin D. de, et al.. (2019). Targeting prenylation inhibition through the mevalonate pathway. RSC Medicinal Chemistry. 11(1). 51–71. 13 indexed citations
15.
Gawel, Justyna M., Yasir S. Raouf, Liying He, et al.. (2019). Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia. ACS Medicinal Chemistry Letters. 11(1). 56–64. 14 indexed citations
16.
Paiva, Stacey-Lynn, et al.. (2017). Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site. Journal of Medicinal Chemistry. 61(2). 405–421. 9 indexed citations
17.
Fong, Robin B., Jordan E. Gardiner, Elvin D. de Araujo, et al.. (2017). Characterization and application studies of ProxyPhos, a chemosensor for the detection of proximally phosphorylated peptides and proteins in aqueous solutions. The Analyst. 142(13). 2451–2459. 8 indexed citations
18.
Araujo, Elvin D. de, et al.. (2017). ProxyPhos sensors for the detection of negatively charged membranes. The Analyst. 142(23). 4511–4521. 9 indexed citations
19.
Araujo, Elvin D. de, Mulu Geletu, & Patrick T. Gunning. (2016). Strategies for over-expression and purification of recombinant full length STAT5B in Escherichia coli. Protein Expression and Purification. 129. 1–8. 8 indexed citations
20.
Araujo, Elvin D. de, et al.. (2015). Phosphorylation-dependent Changes in Nucleotide Binding, Conformation, and Dynamics of the First Nucleotide Binding Domain (NBD1) of the Sulfonylurea Receptor 2B (SUR2B). Journal of Biological Chemistry. 290(37). 22699–22714. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fiona H. Tan Breakdown of academic impact, for papers by Ann Palladino Breakdown of academic impact, for papers by Lata Chauhan Breakdown of academic impact, for papers by Silvia Escudero Breakdown of academic impact, for papers by Ayşe Latif Breakdown of academic impact, for papers by Indranil Basu Breakdown of academic impact, for papers by Ziqian Wang Breakdown of academic impact, for papers by Yvonne Li Breakdown of academic impact, for papers by Alexander Bolaender Breakdown of academic impact, for papers by Sachiko Tai
Rankless by CCL
2026